Chikungunya virus vaccine - Auro Vaccines
Latest Information Update: 02 Feb 2024
At a glance
- Originator Auro Vaccines
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Chikungunya virus infections
Most Recent Events
- 23 Jan 2024 Auro Vaccines files patent for VesiculoVax™ platform (Auro Vaccines pipeline, January 2024)
- 18 Jan 2024 Preclinical trials in Chikungunya virus infections (Prevention) in USA (unspecified route) (Auro Vaccines pipeline, January 2024)